Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraocular Avastin vs no treatment in persistent diabetic macular edema or neovascularisation
2006-003165-13Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Sep 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of bevacizumab in diabetic retinopathy (DR) and diabetic macular edema (DME) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Structural retinal changes. Started Sep 2006; status: terminated.
02
Drugs
bevacizumab
03
Conditions
diabetic retinopathy (DR)diabetic macular edema (DME)
Beyond the preview
Go deeper on 2006-003165-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003165-13.